Few US medical schools and medical centres are disclosing industry tiesBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1075 (Published 23 February 2010) Cite this as: BMJ 2010;340:c1075
- Janice Hopkins Tanne
- 1New York
Few of the leading medical schools and hospitals in the United States tell the public about their academic members’ ties to the drug and device industry, although more institutions now require members to disclose this information to them, say the American Medical Student Association and the Association of American Medical Colleges.
Prominent academic physicians who have not told their institutions about lucrative consulting arrangements with drug and device companies have been headline news in recent years in the US (BMJ 2009;338:a3188, doi:10.1136/bmj.a3188; BMJ 2009;339:b2725, doi:10.1136/bmj.b2725).
The trend is toward greater disclosure, said Kim Cunningham, a spokesperson for the American Medical Students Association. The association has compiled a scorecard of US medical schools’ …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial